A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin

被引:146
|
作者
Lalou, C [1 ]
Lassarre, C [1 ]
Binoux, M [1 ]
机构
[1] HOP ST ANTOINE, INSERM, U142, UNITE RECH REGULAT CROISSANCE, F-75571 PARIS 12, FRANCE
关键词
D O I
10.1210/en.137.8.3206
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3) is increasingly becoming recognized as an essential mechanism in the regulation of insulin-like growth factor (IGF) bioavailability, both in the bloodstream and at cellular level. Plasmin generated on contact with various cell types provokes proteolytic cleavages that ape similar to those induced in vivo by (as yet unidentified) IGFBP-3 proteases. Experimental conditions were determined to achieve plasmin-induced limited proteolysis of recombinant human nonglycosylated IGFBP-9. Two major fragments of 22/25 kilodaltons (kDa) and one of 16 kDa were identified by Western immunoblotting and isolated by reverse-phase chromatography, The 22/25-kDa fragments correspond to the major approximate to 30-kDa glycosylated fragment of IGFBP-3 in serum and the 16-kDa fragment, to one of the same size, that is nonglycosylated. Western Ligand blot analysis, affinity cross-linking, and competitive binding experiments using radiolabeled IGF and unlabeled IGF-I or -II showed that in the high performance liquid chromatography eluate containing the 16-kDa fragment, all affinity for IGFs had been lost, whereas the affinity of the 22/25-kDa fragment was considerably reduced. Scatchard analysis of the data indicated a 20-fold loss of affinity for IGF-II and an 50-fold loss for IGF-I compared with that of recombinant human IGFBP-3. In a chick embryo fibroblast assay in which DNA synthesis was stimulated both by IGF-I and by insulin (at 100-fold concentrations, so that interaction with the Type 1 IGF receptor would occur), IGFBP-3 was found to inhibit IGF-I-induced stimulation almost totally. It had no effect on stimulation by insulin, which has no affinity for the IGFBPs. With the 22/25-kDa fragments, barely 50% inhibition of IGF-I stimulation was achieved and no inhibition of insulin stimulation. Unexpectedly, with the fraction containing the 16-kDa fragment (despite the total lack of affinity for IGF-I), IGF-I-induced stimulation was inhibited to nearly the same extent as with intact IGFBP-3. In addition, insulin-induced stimulation was inhibited with similar potency. IGFBP-3 proteolysis therefore generates two types of fragment with different activities. One has weak affinity for IGF-I and is only a weak antagonist of IGF action. The other lacks affinity for the IGFs, but nevertheless inhibits IGF-stimulated mitogenesis, thus acting by a mechanism that is independent of the IGFs.
引用
收藏
页码:3206 / 3212
页数:7
相关论文
共 50 条
  • [11] INSULIN-LIKE GROWTH FACTOR-(IGF) BINDING PROTEIN-3 IN PREGNANCY SERUM BINDS NATIVE IGF-I BUT NOT IODO-IGF-I
    SUIKKARI, AM
    BAXTER, RC
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1991, 73 (06): : 1377 - 1379
  • [12] Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)
    Lukanova, A
    Söderberg, S
    Stattin, P
    Palmqvist, R
    Lundin, E
    Biessy, C
    Rinaldi, S
    Riboli, E
    Hallmans, G
    Kaaks, R
    CANCER CAUSES & CONTROL, 2002, 13 (06) : 509 - 516
  • [13] OVEREXPRESSION OF INSULIN-LIKE GROWTH-FACTOR BINDING PROTEIN-3 BY SENESCENT HUMAN FIBROBLASTS - ATTENUATION OF THE MITOGENIC RESPONSE TO IGF-I
    GRIGORIEV, VG
    MOERMAN, EJ
    GOLDSTEIN, S
    EXPERIMENTAL CELL RESEARCH, 1995, 219 (02) : 315 - 321
  • [14] Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)
    Annekatrin Lukanova
    Stefan Söderberg
    Pär Stattin
    Richard Palmqvist
    Eva Lundin
    Carine Biessy
    Sabina Rinaldi
    Elio Riboli
    Göran Hallmans
    Rudolf Kaaks
    Cancer Causes & Control, 2002, 13 : 509 - 516
  • [15] Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells
    Hong, J
    Zhang, G
    Dong, F
    Rechler, MM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (12) : 10489 - 10497
  • [16] Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke
    Johnsen, SP
    Hundborg, HH
    Sorensen, HT
    Orskov, H
    Tjonneland, A
    Overvad, K
    Jorgensen, JOL
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (11): : 5937 - 5941
  • [17] PROTEOLYTIC DEGRADATION OF INSULIN-LIKE GROWTH-FACTOR (IGF)-BINDING PROTEIN-3 BY PORCINE OVARIAN GRANULOSA-CELLS IN CULTURE - REGULATION BY IGF-I
    GRIMES, RW
    HAMMOND, JM
    ENDOCRINOLOGY, 1994, 134 (01) : 337 - 343
  • [18] Binding affinities of insulin-like growth factor-I (IGF-I) fusion proteins to IGF binding protein 1 and IGF-I receptor are not correlated with mitogenic activity
    Jansson, M
    Dixelius, J
    Uhlen, M
    Nilsson, BO
    FEBS LETTERS, 1997, 416 (03) : 259 - 264
  • [19] Contribution of insulin-like growth factor (IGF)-I and IGF-binding protein-3 to mitogenic activity in bovine mammary extracts and serum
    Weber, MS
    Purup, S
    Vestergaard, M
    Ellis, SE
    Sondergård-Andersen, J
    Akers, RM
    Sejrsen, K
    JOURNAL OF ENDOCRINOLOGY, 1999, 161 (03) : 365 - 373
  • [20] Insulin-like growth factor-I (IGF-I) and IGF binding protein-3 as predictors of advanced-stage prostate cancer
    Chan, JM
    Stampfer, MJ
    Ma, J
    Gann, P
    Gaziano, JM
    Pollak, M
    Giovannucci, E
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (14) : 1099 - 1106